Li M, Chen X M, Wang D M, Gan L, Qiao Y
Department of Ophthalmology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Department of Ophthalmology, AVIC 363 Hospital of Chengdu, Chengdu, Sichuan, China.
Genet Mol Res. 2016 Jul 14;15(2):gmr8193. doi: 10.4238/gmr.15028193.
The aim of this study was to evaluate the effects of miR-26a on Beclin 1 expression in retinoblastoma (RB) cell lines (Y79 and WERi-RB-1). RB cells were transfected with miR-26a mimic, antagomir-26a, or control mimic. The Beclin 1 mRNA and protein levels were detected by quantitative polymerase chain reaction and western blot, respectively. The activity of Beclin 1 3ꞌ-UTR reporter gene was detected with the luciferase assay. After transfection with miR-26a mimic, Beclin 1 mRNA and protein levels as well as the activity of the 3'-UTR reporter gene decreased. However, all were increased upon inhibition of miR-26a with antagomir-26a. Beclin 1 is the target of miR-26a in human RB cell lines Y79 and WERi-RB-1, and miR-26a inhibits the expression of Beclin 1 by reducing its mRNA and protein levels.
本研究旨在评估miR-26a对视网膜母细胞瘤(RB)细胞系(Y79和WERi-RB-1)中Beclin 1表达的影响。用miR-26a模拟物、抗miR-26a或对照模拟物转染RB细胞。分别通过定量聚合酶链反应和蛋白质印迹法检测Beclin 1的mRNA和蛋白质水平。用荧光素酶测定法检测Beclin 1 3'-UTR报告基因的活性。用miR-26a模拟物转染后,Beclin 1的mRNA和蛋白质水平以及3'-UTR报告基因的活性均降低。然而,用抗miR-26a抑制miR-26a后,所有指标均升高。在人RB细胞系Y79和WERi-RB-1中,Beclin 1是miR-26a的靶标,且miR-26a通过降低Beclin 1的mRNA和蛋白质水平来抑制其表达。